NCT05495425 - Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions

Tuberous Sclerosis Complex

Interventions

DRUG

NPC-12Y gel

NPC-12Y gel is applied twice a day for 12 weeks. After the double-blind evaluation period, NPC-12Y gel is applied twice a day for 52 weeks.

DRUG

NPC-12Y placebo gel

NPC-12Y placebo gel is applied twice a day for 12 weeks. After the double-blind evaluation period, NPC-12Y gel is applied twice a day for 52 weeks.

Trial Locations (5)

Fujita Health University Hospital, Toyoake

Gunma University Hospital, Maebashi

Osaka University Hospital, Suita

Seirei Hamamatsu General Hospital, Hamamatsu

National Hospital Organization Nishi-Niigata Chuo Hospital, Niigata